Maxygen, Inc. Plans Staff Cuts After Forming R&D Joint Venture With Astellas Pharma Inc.

July 1, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

BizJournals -- Maxygen Inc. and Japanese drug maker Astellas Pharma Inc. will start an R&D joint venture focused on protein drugs but largely spelling the beginning of the end of the Redwood City company as it is known today.

Twitter
LinkedIn
Facebook
Email
Print

Job creations

Astellas Pharma US, Inc.